11 – 20 of 33
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing
(
- Contribution to journal › Article
-
Mark
Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer
(
- Contribution to journal › Article
-
Mark
Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab : Results from the Phase II PROMIX trial
(
- Contribution to journal › Article
-
Mark
Immune gene expression and response to chemotherapy in advanced breast cancer
(
- Contribution to journal › Article
- 2017
-
Mark
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
(
- Contribution to journal › Article
-
Mark
PAM50 provides prognostic information when applied to the lymph node metastases of advanced breast cancer patients
(
- Contribution to journal › Article
-
Mark
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
(
- Contribution to journal › Article
-
Mark
Estimating the Risks of Breast Cancer Radiotherapy : Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials
2017) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 35(15). p.1641-1649(
- Contribution to journal › Article
-
Mark
Societal challenges of precision medicine : Bringing order to chaos
(
- Contribution to journal › Article
- 2016
-
Mark
Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer
(
- Contribution to journal › Article